DWDalei Wu

Dalei Wu

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Dalei Wu has a total of 268 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • The hepatic FGFR-ERK-HRG axis regulates heparin-induced thrombocytopenia with thrombosis

    by Shaoyun Zhou, Tianyu Wang, Miguel A. D. Neves, Ming Liu, Kang Liu, Wanying Yang, Jiaojiao Yan, Qisheng Ling, Haidong Chen, Muhammad Awais, et al.

    Heparin-induced thrombocytopenia (HIT) is a life-threatening prothrombotic disorder with substantial clinical mortality, which is characterized by pathologic antibody formation against platelet factor 4 (PF4)–heparin complexes. This study identified early pathologic mechanisms that initiate HIT immune complex formation and regulate thrombus development. We also found that repeated heparin administration over 5 days markedly enhanced platelet activation, which implied an additional activating mechanism. Through plasma proteomic analysis, we observed that histidine-rich glycoprotein (HRG) levels were significantly reduced after successive heparin administration and were inversely related to platelet activation. Mechanistically, heparin and PF4 suppressed HRG expression by inhibiting the FGFR–extracellular signal-regulated kinase (ERK)–ETS domain-containing transcription factor Elk-1 (Elk1) pathway, whereby Elk1 directly binds to the HRG promoter region to regulate its expression in the liver. Physiological levels of HRG potently inhibited platelet activation, procoagulant activity, spreading, and aggregation and significantly reduced thrombus formation under flow conditions. HRG bound to activated αIIbβ3 integrin in a zinc-dependent manner, thereby blocking its ligand-binding capacity. HRG also inhibited the formation of ultralarge PF4-heparin complexes (ULCs), disrupted the ultralarge immune complexes (ULICs) comprising the HIT-like antibody KKO and ULCs, and blocked the binding of KKO to PF4/heparin on platelets. Furthermore, HRG attenuated ULC-triggered autoantibody generation and inhibited ULIC-induced neutrophil extracellular traps and microvascular thrombus formation both in vitro and in a mouse model of HIT. In conclusion, our work establishes HRG as a pivotal regulator of pathologic immune responses and thrombosis in HIT, providing mechanistic insights into disease pathogenesis.


  • Enzymatic Site-Selective Deglycosylation Enhances PPM1A Agonistic Activity of Dammarane Saponins for the Treatment of Hepatic Fibrosis

    by Hanghang Wang, Qi Li, Wenxiu Wang, Zecheng Jin, Xinyi Tong, Yu Zhang, Yue Liu, Huifa Han, Meng Yang, Dalei Wu, et al.

    Carbohydrate moieties profoundly influence target binding, drug-like properties, and mechanism of action, but achieving site-selective editing within complex oligosaccharide chains remains a challenge for conventional chemical methods. We herein report an enzymatic deglycosylation platform that enables precise, site-selective removal of sugar units from branched carbohydrate chains of dammarane-type saponins, the first reported PPM1A phosphatase agonists. SAR analysis confirms the distal xylose removal drastically improves PPM1A agonistic potency versus the parent saponins. Cellular and in vivo assays prove the optimized derivative represses PPM1A-governed TGF-β1/Smad3 and NF-κB p65 phosphorylation. In diverse hepatic fibrosis models, it alleviates fibrotic progression dose-dependently, matching the efficacy of the clinical drug resmetirom at equivalent doses and administration regimens. In conclusion, our findings establish a versatile toolbox for precise modifications of complex carbohydrate moieties under mild conditions and delineate the critical role of specific glycosyl groups in modulating PPM1A activity as a therapeutic strategy for hepatic fibrosis.

  • Author Correction: Gut commensal Christensenella minuta modulates host metabolism via acylated secondary bile acids

    by Chang Liu, Meng-Xuan Du, Li-Sheng Xie, Wen-Zhao Wang, Bao-Song Chen, Chu-Yu Yun, Xin-Wei Sun, Xi Luo, Yu Jiang, Kai Wang, et al.

  • Advances in understanding aryl hydrocarbon receptor structure, function, and modulation

    by Qinghong Shang, Sepideh Khorasanizadeh, Xiaotong Diao, Fraydoon Rastinejad, Dalei Wu


  • Accessing Underexplored Biosynthetic Potential by Initiation Unit Engineering of Nonribosomal Peptide Synthetases in Proteobacteria

    by Xianping Bai, Lin Zhong, Yang Liu, Hanna Chen, Xingxing Shi, Xingyan Wang, Ruichen Xu, Qingsheng Yang, Xiaotong Diao, Shengying Li, et al.

    Nonribosomal peptide synthetases (NRPSs) represent a valuable yet underexplored resource for producing bioactive natural products. However, most NRPSs remain silenced potentially due to factors such as dysfunction of the initiation unit. The starter condensation (Cs) domain of the initiation unit catalyzes the lipoinitiation of nonribosomal peptides via the incorporation of an N-terminal fatty acyl chain. The concept of initiation unit engineering introduced herein encompasses the replacement of the native initiation unit of NRPSs with a foreign and well-characterized Cs domain-containing initiation unit to activate the NRPS and optimize its expression. This strategy was employed herein to successfully access three of the six previously silent NRPS pathways in Mycetohabitans rhizoxinica HKI 454, a bacterium of the class β-proteobacteria, resulting in the identification of three classes of lipopeptides. This strategy was then extended to access two NRPS pathways in Pseudomonas syringae (γ-proteobacteria) and obtain novel lipopeptides, thereby establishing a feasible complement to existing genome mining strategies for natural product discovery. Furthermore, change of the initiation regions of biosynthetic pathways of nonlipidated chitinimide (β-proteobacteria) and pseudotetraivprolide (γ-proteobacteria) with heterologous Cs-containing initiation units enabled the successful incorporation of fatty acyl chains into the N-terminus of both peptide backbones, launching a workable approach to create artificial lipopeptides. Overall, this study provides a practical strategy for the rational recovery of silent BGCs and introduction of fatty acyl chains into nonribosomal peptides, at least in Proteobacteria, thereby enriching genome mining and combinatorial biosynthesis approaches for accessing the underexplored biosynthetic potential of NRPSs from various bacteria.


  • Open Access

    Targeting PTPN13 with 11-amino-acid peptides of C-terminal APC prevents immune evasion of colorectal cancer

    by Wen-Hui Ma, Wen-Yi Li, Tao Chen, Linqian Jing, Yue-Hong Chen, Kejun Li, Zhuo-Luo Xu, Rong-Fang Shen, Yutong He, Tingyu Mou, et al.

    Colorectal cancer (CRC) remains largely refractory to immune-checkpoint blockade, with adenomatous polyposis coli ( APC ) mutations present in 80%–90% of cases. Loss of APC was previously thought to promote tumor progression mainly through deregulated Wnt/β-catenin signaling. Here, we report that APC loss leads to inhibition of CD8 + T cell infiltration and CRC immune evasion through the dephosphorylation of signal transducers and activators of transcription 1 (STAT1) by protein tyrosine phosphatase non-receptor type 13 (PTPN13), independently of β-catenin. Peptides containing the last 11 C-terminal amino acid (aa) residues of APC (APC11) bind directly to PTPN13 to block PTPN13–STAT1 interactions and facilitate STAT1 phosphorylation, interferon regulatory factor-1 (IRF1) expression, major histocompatibility complex (MHC) class I antigen presentation, and T cell intratumoral infiltration, all of which eventually inhibit tumor progression and enhance the effects of programmed cell death 1 (PD1) blockade. Thus, we have identified a previously unknown APC/PTPN13/STAT1-dependent tumor immune-suppressive mechanism. The potent tumor-suppressing effect of combining anti-PD1 antibodies with APC11 peptides provides a compelling target and rationale for future development of anti-tumor drugs for patients with CRC.


  • Structure-Based Optimization of HIF-2α Agonists That Synergistically Enhance Erythropoietin Production with PHD Inhibitors

    by Mengqi Guo, Weiwei Xu, Zhifang Bai, Keming Chen, Fengyao Li, Zecheng Jin, Xiaoyu Chen, Qinghong Shang, Meina Zhang, Xiaotong Diao, et al.

    Hypoxia-inducible factor 2α (HIF-2α) is a crucial transcription factor regulating various physiological processes, including angiogenesis and erythropoiesis. The activity of HIF-2α is mainly controlled through oxygen-dependent protein hydroxylation, mediated by prolyl hydroxylase domain (PHD) enzymes, leading to subsequent HIF-2α ubiquitination and degradation. While several small-molecule PHD inhibitors have already been clinically applied in renal anemia treatment by indirectly activating the HIF-2α pathway, direct HIF-2α agonists remain largely unexplored. Here, we developed derivatives of HIF-2α agonist M1001, identifying SD-10 through molecular/cellular evaluations. By determining its cocrystal structure with the heterodimeric HIF-2 protein complex, we precisely characterized its molecular mechanism of action. Notably, SD-10 exhibited remarkable synergy with Daprodustat, an approved PHD inhibitor, in stimulating erythropoietin (EPO) secretion both in cellular models and animal studies. These findings not only provide insights into HIF-2α activation mechanism, but also offer a promising lead compound for developing innovative treatments for renal anemia.


  • Molecular mechanism of the crosstalk between glucocorticoid receptor (GR) and hypoxia-inducible factor 3α (HIF-3α) pathways

    by Meina Zhang, Yang Guo, Xiaotong Diao, Mengqi Guo, Huiling Teng, Xiangnan Sun, Jingjing Zhuang, Chun Song, Xiangyang Xie, Dalei Wu

    Glucocorticoids, crucial regulatory hormones involved in the stress response, significantly influence growth, development, and metabolism through activation of the glucocorticoid receptor (GR). Hypoxia-inducible factor 3 alpha (HIF-3α), the least characterized paralog among three HIF-α proteins, plays a role in adaptation to oxygen level changes and metabolic reprogramming. Despite the potential functional overlaps between GR and HIF-3α pathways in regulating metabolism, their crosstalk remains poorly understood. Here, we demonstrate a regulatory mechanism governing the crosstalk between these two transcription factor pathways. We found that upon ligand activation, GR binds to the intronic region of the HIF3A gene and upregulates its mRNA transcription. Additionally, HIF-3α and GR engage in protein–protein interactions through the oxygen-dependent degradation domain of HIF-3α and all major domains of GR (i.e. the N-terminal, DNA-binding, and ligand-binding domains). Furthermore, we discovered that this interaction results in reciprocal attenuation of the transcriptional activities of both GR and HIF-3α, causing a negative feedback loop upon HIF3A gene expression. The GR-HIF-3α interaction may offer a targetable pivot to modulate these two TF pathways, potentially providing a novel therapeutic avenue for related diseases.


  • Open Access

    Rbm24a dictates mRNA recruitment for germ granule assembly in zebrafish

    by Yizhuang Zhang, Jiasheng Wang, Hailing Fang, Shuqi Hu, Boya Yang, Jiayi Zhou, Raphaëlle Grifone, Panfeng Li, Tong Lu, Zhengyang Wang, et al.

    The germ granules are ribonucleoprotein (RNP) biomolecular condensates that determine the fate of primordial germ cells (PGCs) and serve as a model for studying RNP granule assembly. Here, we show that the maternal RNA-binding protein Rbm24a is a key factor governing the specific sorting of mRNAs into germ granules. Mechanistically, Rbm24a interacts with the germ plasm component Buc to dictate the specific recruitment of germ plasm mRNAs into phase-separated condensates. Germ plasm particles lacking Rbm24a and mRNAs fail to undergo kinesin-dependent transport toward cleavage furrows where small granules fuse into large aggregates. Therefore, the loss of maternal Rbm24a causes a complete degradation of the germ plasm and the disappearance of PGCs. These findings demonstrate that the Rbm24a/Buc complex functions as a nucleating organizer of germ granules, highlighting an emerging mechanism for RNA-binding proteins in reading and recruiting RNA components into a phase-separated protein scaffold.


  • Open Access

    De novo discovery of a molecular glue–like macrocyclic peptide that induces MCL1 homodimerization

    by Fengwei Li, Mengmeng Zhang, Chao Liu, Jie Cheng, Yawen Yang, Xiangda Peng, Zhifeng Li, Wenfeng Cai, Haipeng Yu, Junjie Wu, et al.

    Macrocyclic peptides have emerged as promising drug candidates, filling the gap between small molecules and large biomolecules in drug discovery. The antiapoptotic protein myeloid cell leukemia 1 (MCL1) is crucial for numerous cancers, yet it presents challenges for selective targeting by traditional inhibitors. In this study, we identified a macrocyclic peptide, 5L1, that strongly binds to MCL1, with a dissociation constant ( K D ) of 7.1 nM. This peptide shows the potential to specifically inhibit the function of MCL1, and demonstrates effective antitumor activity against several blood tumor cell lines with the half maximal inhibitory concentration (IC 50 ) values for cell-penetrating peptide-conjugated 5L1 in the range of 0.6 to 3 μM. Structural analysis revealed that it functions similarly to molecular glue, capable of binding to two MCL1 molecules simultaneously and inducing their homodimerization. This unique mechanism of action distinguishes it from traditional small-molecule MCL1 inhibitors, underscoring the potential of macrocyclic peptides functioning as molecular glues. Moreover, it inspires the development of highly selective inhibitors targeting MCL1 and other related targets with this glue-like mechanism.